Post-Pandemic Biosensor Boom Sustains Momentum: At-Home Testing Market Valued at $12.7 Billion by 2030
The COVID-19 pandemic accelerated biosensor adoption, particularly for at-home testing and remote monitoring, and this momentum shows no signs of slowing. Rapid antigen tests introduced millions to biosensor technology, fostering familiarity and demand. Today, the at-home biosensor testing market, valued at $4.1 billion in 2023, is projected to reach $12.7 billion by 2030, growing at a 21.4%...
0 التعليقات 0 المشاركات 25 مشاهدة 0 معاينة